Production assistance for cellular therapies (pact)- cell processing facilities

Ended Awarded Last action

Contract number
HHSN268201600011I
Awardee
Awarding agency
Task orders
6 $5,501,451 obligated

Award facts

Opportunity
  • NHLBIECBHB201609JB Solicitation number
Combined order value
$5,501,451 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 12% used
$45,630,651.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
10 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The National Heart Lung and Blood Institute awarded an indefinite-delivery contract to Beckman Research Institute Of The City Of Hope on July 29, 2016, with a ceiling of $45.63 million and ultimate completion date of June 30, 2022. This is a multiple-award IDIQ with no set-aside designation.

The contract procures production assistance for cellular therapies and cell processing facilities, supporting NIH research into regenerative medicine and cardiovascular disease treatment through human embryonic stem cell (hESC) and induced pluripotent stem cell (iPSC) derived cardiomyocyte cell production, hematopoietic stem cell gene modification, and associated manufacturing and process development services.

Place of performance is Irwindale, California and Minneapolis, Minnesota. The contract period runs from award through June 30, 2022, with base and option periods structured within that ultimate completion date.

Delivery orders issued under this IDIQ include a $1.68 million order awarded July 10, 2017 for cell manufacturing and process development services for hESC and iPSC derived cardiomyocyte cell production (completion July 9, 2019); a $1.49 million order for production assistance for cellular therapies awarded July 10, 2017 (completion July 9, 2019); a $662,778 order for cell manufacturing and process development services for stem cell-derived cardiomyocyte cell production awarded September 29, 2017 (completion March 31, 2022); a $872,250 firm-fixed-price order for administrative and regulatory program support services under Task Area #1 awarded August 1, 2016 in Minneapolis, Minnesota (completion June 30, 2021); a $583,417 order for cell manufacturing and process development services awarded September 28, 2017 (completion October 9, 2018); and a $211,855 order for hESC-derived cardiomyocyte progenitor cells for preclinical animal studies awarded October 20, 2020 (completion July 20, 2021). All delivery orders are priced on a cost-no-fee basis except the Task Area #1 order, which is firm-fixed-price.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $0
Original award $0

Quick answers

Who was awarded contract HHSN268201600011I?

HHSN268201600011I was awarded to Beckman Research Institute Of The City Of Hope by National Heart Lung and Blood Institute (National Institutes of Health) on July 29, 2016.

How much is contract HHSN268201600011I worth?

Orders under HHSN268201600011I have obligated $5,501,451. HHSN268201600011I's own ceiling is $45,630,651.

How many orders have been placed under contract HHSN268201600011I?

6 orders have been placed under HHSN268201600011I, the latest on October 20, 2020.

Who can order from contract HHSN268201600011I?

HHSN268201600011I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN268201600011I part of a contract vehicle?

Yes. HHSN268201600011I is part of Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF).

Was contract HHSN268201600011I competed?

The government received 10 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV